Program Nearly Full CEO Profile
Invited Companies: If you have already been invited to present and wish to confirm your spot please do so immediately.
New Companies: If you have not received an invitation but wish to be considered, please fill out the application above and if approved we will contact you regarding your place on the wait-list.
Activ Surgical CEO Profile
Improving patient outcomes and reducing costs to healthcare systems through the integration of advanced computer vision, artificial intelligence and robotics designed to seamlessly fit within operating room workflow while providing advanced imaging and diagnostic accuracy during surgery.
Alucent Biomedical CEO Profile
Natural Vascular Scaffolding (NVS) is the first technology of its kind combining drug-device therapy into a breakthrough treatment designed to naturally open narrowed or blocked arteries and then durably maintain arterial patency. NVS was developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD).
Articulate Labs CEO Profile
Wearable medical devices that augment regular activity to create convenient, mobile physical rehabilitation assistance. The first application of this platform technology is accelerated rehabilitation following knee replacement surgery through neuromuscular electrical stimulation of user's quadriceps muscles in synch with gait.
Ayogo Health CEO Profile
Digital health company improving engagement, adherence to program, and ultimately health outcomes for patients across a variety of conditions. The first product, Empower, has been successfully deployed for patients around the world to increase activation, adherence, and persistence to therapy.
Biorez CEO Profile
Biorez is developing bio-inductive implants for the $7B sports medicine market that help restore joint stability and help direct the healing and regeneration of new functional tissue. After the healing process is complete, our implants are naturally broken down by the body, restoring the anatomy without the chronic risks of permanent synthetic materials.
Canary Medical CEO Profile
A medical data company improving healthcare outcomes through the continuous collection, analysis, and monetization of data derived from proprietary, "smart" medical devices that self-report on function, diagnostic information, patient activity, and side effects.
CivaTech Oncology CEO Profile
Innovative products that bring meaningful improvements to low dose rate brachytherapy. The CivaString® and CivaSheet® can substantially reduce procedure time, provide homogeneous dose distribution and minimize trauma. Customizable CivaTech products insure that radiation oncologists can deliver individualized, targeted therapy to treat cancer.
Colospan CEO Profile
An innovative intraluminal bypass device, preventing the profound clinical and economic pains associated with anastomotic leaks and diverting colonic stomas.
The company has achieved meaningful clinical milestones to date, is CE marked and has launched its FDA pivotal trial in Q3-19.
E-Scopics CEO Profile
E-Scopics is a French startup which democratizes ultrasound imaging to all healthcare professionals. It manufactures a digital transducer and a connected software APP to provides quantitative imaging for several medical conditions. The image formation process is no longer HW based but rather a SaaS running on a cell phone, a Tablet or the Cloud, with AI based algorithms for quantitative diagnosis.
HAPPE Spine CEO Profile
Hydroxyapatite Porous PEEK (HAPPE) fabricated through proprietary technology to provide optimal mechanical properties of PEEK polymer materials, while providing improved surface texture inviting boney engagement, interconnected porosity for long term fixation, and the bioactive properties of HA to provide an effective construct for bone ingrowth. The HA further improves mechanical properties compared to standard PEEK, and all together, optimizes imaging for post operative diagnosis.
Icaria Medical CEO Profile
Dedicated to the development of the first continuous non-invasive blood pressure monitor, which is accurate and capable of tracking all fluctuations. By using a bracelet, real-time and unassisted monitoring, and AI algorithms, the system is capable of preventing cardiovascular events.
LifeWave Biomedical CEO Profile
A connected health solution that improves the clinical management of patients living with congestive heart failure (CHF) in hospital, ambulatory, and home settings. The solution comprises a small, non-invasive lung sensor that provides an absolute and accurate measurement of lung fluids and respiratory parameters.
LightIntegra Technology CEO Profile
A medical device company focused on reducing transfusions, minimizing platelet refractoriness and reducing healthcare costs for blood cancer patients. The device, ThromboLUX, makes a rapid determination of platelet activation status, thus allowing proper allocation of platelet products to patient recipients.
Medical 21 CEO Profile
Developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.
Nanochon CEO Profile
Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3-D printing to create an implant which can permanently repair debilitating joint injuries. The implant can bear loads like a traditional joint implant, quickly restoring a patient’s movement.
NeuEsse CEO Profile
Plant-based human skin substitute in either a protein material bandage or a "no-touch" application protocol device (especially for burns) that is lightweight, portable, military-grade and available at any point of injury to deliver skin substitutes along with other therapeutics for military and civilian patients.
ReSymmetry CEO Profile
Healy is a pioneering proprietary technology, developed to introduce controlled, gentle movement of wheelchair elements, to meet the urgent need of wheelchair users. The individually tailored movement programs will improve blood circulation, greatly reduce the risk of secondary medical conditions, enhance wellbeing and improve the quality of life.
Saranas CEO Profile
The Early Bird® is designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as transcatheter aortic valve replacement, large bore hemodynamic support device placement, or other complex endovascular interventions, where the femoral artery or vein is used to gain vascular access.